8.21093
2-Methyltetrahydrofuran
(stabilised) for synthesis
Synonim(y):
2-MeTHF, Tetrahydro-2-methylfuran, Tetrahydrosilvan
Wybierz wielkość
| Do Państwa/SKU | Dostępność | Cena netto |
|---|---|---|
250 mL | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 278,00 zł |
Informacje o tej pozycji
278,00 zł
grade
synthesis grade
Quality Segment
vapor pressure
136 hPa ( 20 °C)
assay
≥98% (GC)
form
liquid
autoignition temp.
270 °C
potency
300-2000 mg/kg LD50, oral (Rat), >2000 mg/kg LD50, skin (Rat)
expl. lim.
1.2-5.7 % (v/v)
dilution
(for synthesis)
refractive index
n20/D 1.406 (lit.)
bp
78-80 °C (lit.)
mp
-136 °C
transition temp
flash point -11 °C
solubility
150 g/L
density
0.86 g/mL at 25 °C (lit.)
storage temp.
2-30°C
SMILES string
CC1CCCO1
InChI
1S/C5H10O/c1-5-3-2-4-6-5/h5H,2-4H2,1H3
InChI key
JWUJQDFVADABEY-UHFFFAOYSA-N
Application
- Production of microalgal-based carbon encapsulated iron nanoparticles (ME-nFe) to remove heavy metals in wastewater: This study explores the application of ammonium iron(III) sulfate dodecahydrate in the synthesis of microalgal-based carbon encapsulated iron nanoparticles. These nanoparticles are used for the efficient removal of heavy metals from wastewater, presenting a significant advancement in environmental cleanup technologies (Mantovani et al., 2023).
- pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles: This research utilizes ammonium iron(III) sulfate dodecahydrate in the development of sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles. These nanoparticles are designed for the pH-responsive controlled release of hydrophobic anti-cancer drugs, offering potential enhancements in targeted cancer therapy (Manatunga et al., 2017).
Analysis Note
Density (d 20 °C/ 4 °C): 0.852 - 0.855
Peroxide (as H₂O₂): ≤ 0.005 %
Identity (IR): passes test
The material is stabilised with Butylhydroxytoluene (BHT).
At time of analytical testing a content of >100 ppm stabiliser was determined.
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description (stabilised) for synthesis | description BioRenewable, ReagentPlus®, ≥99.5%, contains 150-400 ppm BHT as stabilizer | description BioRenewable, anhydrous, ≥99.0%, contains 150-400 ppm BHT as stabilizer | description anhydrous, contains 250 ppm BHT as stabilizer, ZerO2®, ≥99.0% |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| grade synthesis grade | grade - | grade anhydrous | grade ZerO2® |
| assay ≥98% (GC) | assay ≥99.5% | assay ≥99.0% | assay ≥99.0% |
| solubility 150 g/L | solubility - | solubility - | solubility - |
| form liquid | form liquid | form liquid | form liquid |
| density 0.86 g/mL at 25 °C (lit.) | density 0.86 g/mL at 25 °C (lit.) | density 0.86 g/mL at 25 °C (lit.) | density 0.86 g/mL at 25 °C (lit.) |
Still not finding the right product?
Explore all of our products under 2-Methyltetrahydrofuran
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Skin Irrit. 2
supp_hazards
Klasa składowania
3 - Flammable liquids
flash_point_f
14.0 °F - closed cup
flash_point_c
-10.0 °C - closed cup
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.